肿瘤防治研究2011，Vol.38Issue(4)：455-457,3.DOI:10.3971/j.issn.1000-8578.2011.04.024
云克和89Sr联合应用在骨转移癌治疗中的价值
Value of 99Tc-MDP Combining with 89Sr in Therapy of Osseous Metastasis in Patients with Tumor
于仁波 1孙振秀 2王青民1
作者信息
- 1. 266042,山东青岛,青岛市肿瘤医院核医学科
- 2. 山东省青岛市中心血站
- 折叠
摘要
Abstract
Objective To investigate the therapeutic efficacy of 99Tc-MDP combining with 89Sr in alleviating pain of patients with osseous metastasis. Methods 89Sr 3mci was intravenously injected into 120 patients with osseous metastasis, after a week, 99Tc-MDP, 22mg/d, was intravenously injected for 10 days. One course of treatment was one month and was carried on 3 to 6 months; 89Sr was used in every 3 to 4 months, three times at most. Results The pain was significant relieved in 107 patients,relieved in 8 patients, and inefficient in 5 patients. The effective power was 96％ (relieve in 2 or 3 weeks); The time extended more than a year and a half. Myelosuppression was occured in few patient;Some patients with destruction of bone were obviously recovered. Conclusion There are conspicuous effect of 99 Tc-MDP combining with 89Sr in therapying patients with osseous metastasis and conspicuous recovery for destruction of bone induced by osseous metastasis; Patients with osseous metastasis should be treated with 99Tc-MDP combining with 89Sr at an early date.关键词
骨转移癌/云克/89Sr/止痛/修复Key words
Metastatic carcinoma of bone/ 99 Tc-MDP/ 89 Sr/ Relieve pain/ Recovery分类
医药卫生引用本文复制引用
于仁波,孙振秀,王青民..云克和89Sr联合应用在骨转移癌治疗中的价值[J].肿瘤防治研究,2011,38(4):455-457,3.
